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Dystrophin-related protein (DRP or utrophin) is an autosomal homologue of dystrophin, a membrane cytoskeletal protein encoded by the 
Duchenne muscular dystrophy gene. In contrast to dystrophin which is predominantly expressed in muscle, DRP is expressed in various tissues. 
Here we report he purification and biochemical characterization f DRP from lung which shows the highest levels of DRP expression among adult 
tissues. DRP was purified from the high alkaline xtract of lung membranes u ing heparin-agarose column chromatography followed by anti-DRP 
immunoaffinity column chromatography. DRP was expressed in the cultured pulmonary artery endothelial cells. Expression of DRP in endothelial 
cells could explain its abundant expression in lung. In analogy to dystrophin of muscle cells, DRP could be playing an important role in the 
mechanical stress mechanisms of endothelial cells. 
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1. INTRODUCTION 
Duchenne muscular dystrophy (DMD) patients and 
mdx mice are characterized by the absence of dystro- 
phin, a large membrane cytoskeletal protein encoded by 
the DMD gene on the X chromosome [1,2]. Dystrophin 
is associated with a large oligomeric omplex of sar- 
colemmal glycoproteins, including dystroglycan which 
provides a linkage to the extracellular matrix compo- 
nent, laminin [3-10]. In DMD patients and mdx mice, 
the absence of dystrophin leads to a great reduction in 
all of the dystrophin-associated proteins in the sar- 
colemma, thus causing the disruption of the linkage 
between the subsarcolemmal cytoskeleton and the ex- 
tracellular matrix [4,9 11]. 
Recently, a transcript of similar size and high homol- 
ogy to dystrophin was cloned from skeletal muscle, and 
the gene was mapped to chromosome 6 in human and 
chromosome 10 in mouse [12,13]. Immunoblot analysis 
of skeletal muscle homogenates has shown that the pro- 
tein product of this gene, dystrophin-related protein 
(DRP or utrophin), is similar in size to dystrophin [14~ 
21]. In adult skeletal muscle, DRP is localized to the 
neuromuscular junction [15,17-20,22], where it is asso- 
ciated with a large oligomeric omplex of sarcolemmal 
glycoproteins which are identical with or antigenically 
similar to the dystrophin-associated proteins [22]. A 
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possibility that the upregulation of DRP could have 
compensatory effects for dystrophin deficiency was 
raised [18-20,22,23], based on the findings that DRP is 
overexpressed and the dystrophin/DRP-associated pro-
teins are preserved in the small-caliber skeletal and car- 
diac muscles of mdx mice which show minimal pa- 
thological changes [22]. 
The homology of the amino acid sequence between 
DRP and dystrophin is high for the two domains which 
have important physiological functions [2,12,24]: (1) the 
amino-terminal domain which contains the actin-bind- 
ing site [2,25-27]; and (2) the cysteine-rich and carboxyl- 
terminal domains which are involved in the interaction 
with the sarcolemmal glycoprotein complex in skeletal 
muscle [28,29]. On the other hand, the sequence homol- 
ogy between these two proteins is relatively low for the 
rod domain which consists of repeats of triple helix 
[2,24]. The tissue distribution of DRP and dystrophin 
is also different. Dystrophin is predominantly expressed 
in muscle and neuronal cells, while DRP is expressed in 
various tissues including brain, choroid plexus, muscle, 
lung, liver, kidney, testis and placenta, and in various 
cultured cell lines [14,16,19,21,30], suggesting distinct 
biochemical characteristics and functions of these two 
homologous proteins. However, the biochemical char- 
acteristics and function of DRP in non-muscle tissues 
remain unknown. 
In the present study, we report for the first time the 
purification of DRP from lung, which shows the highest 
levels of DRP expression among adult tissues. We also 
demonstrate he expression of DRP in cultured pulmo- 
nary artery endothelial cells. Our results suggest that the 
Published by Elsevier Science Publishers B.V. 289 
Volume 326, number 1,2,3 FEBS LETTERS July 1993 
express ion o f  DRP in endothe l ia l  cells cou ld  expla in its 
abundant  express ion in lung. 
2. EXPERIMENTAL  
2.1. Purification of DRP from lung and skeletal muscle 
Crude membranes were prepared from lung, skeletal muscle (back 
and hindlimb muscles), cardiac muscle, small intestine, brain, liver, 
kidney and spleen of adult rabbit as described previously [31]. KC1- 
washed heavy microsomes were prepared from skeletal muscle of adult 
rabbit as described previously [3,4,6]. 
Crude lung membranes orKCl-washed heavy microsomes ofskele- 
tal muscle (1,500 mg) were suspended in 50 mM Tris-HC1, pH 7.4, 
containing 0.1 mM PMSF and 0.75 mM benzamidine (buffer A) at the 
protein concentration f 5 mg/ml. The suspension was titrated to pH 
11 by slowly adding 1 N NaOH, extracted by gentle stirring for 1 h 
at room temperature and then centrifuged in a Beckman Type 45 Ti 
rotor at 140,000 × g for 30 min at 25°C. After 4 M NaC1 was added 
to the supernatant to a final concentration of 0.15 M NaCI, the 
supernatant was titrated to pH 7.4 by slowly adding 1 N HCI, cooled 
in ice immediately, titrated to pH 7.4 again at 4°C and centrifuged in
a Beckman Type 45 Ti rotor at 140,000 xg for 30 min at 4°C. The 
supernatants were circulated overnight on a 40 ml Heparin-agarose 
column pre-equilibrated with buffer A containing 0.15 M NaC1. After 
extensive washing with buffer A containing 0.15 M NaCI, the column 
was eluted with 150 ml of buffer A containing 0.6 M NaC1. 
Anti-DRP immunoaffinity column was prepared by cross-linking 
antibody against DRP with protein A-Sepharose beads as described 
previously [22]. The 0.6 M NaCI eluates of the heparin-agarose col- 
umn chromatography were diluted 1.2 times with buffer A and circu- 
lated overnight on a 20 ml protein A-Sepharose column pre-equili- 
# 
Fig. 1. Distribution of DRP in tissues of adult rabbit. Membranes (250 
/~g) from cardiac muscle, skeletal muscle, small intestine, brain, liver, 
lung, kidney and spleen were fractionated by 3-12% SDS-PAGE, 
transferred to nitrocellulose membranes and immunostained with an- 
tibody against DRE 
brated with buffer A containing 0.5 M NaC1. The voids of the protein 
A-Sepharose column chromatography were circulated overnight on a 
5 ml anti-DRP immunoaffinity column pre-equilibrated with buffer 
A containing 0.5 M NaCI. After extensive washing with buffer A 
containing 0.5 M NaCl, the column was eluted with 20 ml of 0.1 M 
glycine-HC1, pH 3.0, 0.1 mM PMSF, 0.75 mM benzamidine and 0.5 
M NaCI followed by 40 ml of buffer A containing 0.5 M NaC1. 
Four-ml fractions were collected and neutralized with 2 M Tris-HCl, 
pH 8.0, immediately. 
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Fig. 2. Heparin-agarose column chromatography of proteins extracted from rabbit lung membranes byhigh-alkaline treatment. Crude membranes 
(lane 1), the combined pellets of two centrifugations after alkaline extraction (lane 2), the supernatant of the second centrifugation (lane 3), the 
0.6 M NaCI eluate of the heparin-agarose column chromatography (lane 4) and the void of the protein A-Sepharose column chromatography (lane 
5) were fractionated by 3-12% SDS-PAGE. Shown are the Coomassie blue-stained gel (CB) and identical nitrocellulose transfers immunostained 
with antibody against DRP (C'-DRP) or dystrophin (C'-DYS). Molecular weight standards (x 10 -3) are shown on the left. Immunoglobulin G (IgG), 
which was present in the lung membranes and was immunostained by peroxidase-labeled anti-rabbit IgG secondary antibody, did not bind to the 
heparin-agarose column in the presence of 0.15 M NaC1. 
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2.2. Identification of DRP in the cuhured pulmonary artery endothelial 
cells" 
Porcine pulmonary arteries were obtained immediately after slaugh- 
ter at a local abattoir. Resected ends of" the arteries were clamped, and 
the artery segment briefly immersed in70% ethanol then immediately 
rinsed in M199 with penicillin (100 units/ml) and streptomycin (100 
/tg/ml) (lXP + S). Arteries were then unclamped and placed in sterile 
M199 with 1XP + S. In the laboratory, the arteries were opened lon- 
gitudinally and the lumen gently scraped with a cotton tipped applica- 
tor. Cells were released into 35 mm diameter tissue culture dishes with 
M199 supplemented with Basal Medium Eagle vitamins and amino 
acids, 1XP+S, 10% fetal bovine serum and then incubated at 37°C in 
5% CO2 and 95% air. Cultures were demonstrated to be endothelial 
by morphology and by the uptake of acetylated low density lipopro- 
tein [32]. Cells were subcultured 3:1 twice weekly using 0.25% tryp- 
sin:0.1% EDTA, and cultures from passages 4 through 10 were used. 
Cultured endothelial cells were extracted on the dish for l0 min at 
room temperature with extraction buffer consisting of l0 mM PIPES- 
NaOH, pH 7.4, 100 mM sodium pyrophosphate, 1%digitonin, 0.5 M 
NaC1, 0.5 M sucrose, 1mM EGTA, 2 mM MgCI2. 5 mM aminocaproic 
acid, 0.1 mM PMSF, 5 mM benzamidine, 100/IM leupeptin and 80 
/lg/ml of aprotinin. The extract (1 ml) was incubated at 4°C overnight 
with 100 ,ul of the anti-DRP immunoaffinity beads which were pre- 
equilibrated with extraction buffer. After centrifugation, the superna- 
tants were decanted and analyzed by immunoblotting. 
2.3. Antibodies 
Affinity-purified rabbit polyclonal antibody against he last 12 
amino acids of the C-terminus of DRP, rabbit polyclonal antibody 
against he last 10 amino acids of the C-terminus of dystrophin and 
two monoclonal antibodies against dystrophin, VIA42 and XIXC2, 
were characterized previously [4,~11,17,22,33]. 3-12% SDS-poly- 
acrylamide gel electrophoresis (PAGE) and immunoblotting were per- 
formed as described previously [3,4]. 
3. RESULTS AND DISCUSSION 
Immunoblot analysis of membranes from various tis- 
sues of adult rabbit demonstrated that the highest levels 
of DRP expression were in lung, although it was also 
detected in small intestine, skeletal muscle, cardiac mus- 
cle, liver, kidney and brain (Fig. 1). We have previously 
demonstrated that the dystrophin-glycoprotein com- 
plex is dissociated at pH 11 [6]. Further investigation 
has revealed that dystrophin, a membrane cytoskeletal 
protein, is extracted from skeletal muscle membranes by 
the pH 11 treatment, while the dystrophin-associated 
glycoproteins remain in the membranes [34]. We de- 
cided to perform the pH 11 extraction of the membranes 
from lung and skeletal muscle as the initial step for the 
purification of DRE DRP was extracted from both 
crude lung membranes and KCl-washed heavy micro- 
somes of skeletal muscle by this procedure (Figs. 2 and 
3), suggesting that DRP may also be a membrane cy- 
toskeletal protein like dystrophin. 
After the overnight circulation on the heparin-aga- 
rose column in the presence of 0.15 M NaC1 and the 
extensive wash of the column, the bound proteins were 
eluted with a buffer containing 0.6 M NaC1. DRP eluted 
completely in the 0.6 M NaC1 buffer (Figs. 2 and 3). 
Dystrophin was not detected in lung, while dystrophin 
co-purified with DRP from skeletal muscle during these 
procedures (Figs. 2 and 3). These results are consistent 
CB C ' -DRP C' -DYS 
224 - 
109 - 
72 -  
46-  
DRP ~ ~ DYS 
29-  
1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 
Fig. 3. Heparin-agarose column chromatography of proteins extracted from rabbit skeletal muscle membranes by high-alkaline treatment. 
KCl-washed heavy microsomes (lane 1), the combined pellets of two centrifugations after alkaline xtraction (lane 2), the supernatant of the second 
centrifugation (lane 3), the 0.6 M NaCI eluate of the heparin-agarose column chromatography (lane 4) and the void of the protein A-Sepharose 
column chromatography (lane 5) were fractionated by 3-12% SDS-PAGE. Shown are the Coomassie blue-stained gel (CB) and identical nitrocel- 
lulose transfers immunostained with antibody against DRP (C'-DRP) or dystrophin (C'-DYS). 
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Fig. 4. Purification of DRP using the anti-DRP immunoaffinity column chromatography. The peak fractions of the anti-DRP immunoaffinity 
column eluates from skeletal muscle (lane 2) and lung (lane 3) were fractionated by 3 12% SDS-PAGE together with dystrophin isolated from rabbit 
skeletal muscle as described previously (lane 1) [6]. CB indicates the gel stained with Coomassie blue. Identical nitrocellulose transfers were 
immunostained with antibody against DRP (C'-DRP) or antibodies against dystrophin (C'-DYS, VIA4 2 and XIXC2). 
with the high homology between DRP and dystrophin. 
The eluates of the heparin-agarose column chroma- 
tography from lung and skeletal muscle were circulated 
on the protein A-Sepharose column to remove proteins 
which may bind to this matrix. The voids were circu- 
lated overnight on the anti-DRP immunoaffinity col- 
umn. After extensive washing, the column was eluted 
with 0.1 M glycine-HC1, pH 3.0, containing 0.5 M 
NaC1. The resulting protein from both lung and skeletal 
muscle appeared as a band with molecular mass of ap- 
proximately 400 kDa on 3 12% SDS-PAGE and was 
immunostained by antibody against DRP but was not 
stained by several antibodies against dystrophin, de- 
monstrating that it was DRP (Fig. 4). 
So far the cellular distribution of DRP in lung has not 
been established. We performed the immunofluores- 
cence localization of DRP in lung but a high level of 
non-specific backgound staining, which was presumed 
to be due to the high abundance of immunoglobulins 
(Fig. 2), hindered the localization of DRP in lung by this 
method (not shown). In skeletal muscle, DRP was de- 
tected in the capillaries, in addition to the neuromuscu- 
lar junctions (not shown). This suggested that DRP 
could be expressed in the endothelial cells which are 
abundant in lung. We investigated this possibility using 
cultured pulmonary artery endothelial cells. The dig- 
itonin-extracts of the cultured pulmonary artery endo- 
thelial cells were subjected to immunoprecipitation 
by the anti-DRP immunoaffinity beads. Immunoblot 
analysis demonstrated that DRP was expressed in pul- 
monary artery endothelial cells (Fig. 5). DRP in the 
digitonin-extracts was precipitated completely by the 
anti-DRP antibody (Fig. 5). DRP was also detected in 
the cultured umbilical vein endothelial cells and cul- 
tured microvascular cells by immunoblot analysis (not 
shown). These findings suggest hat the expression of 
DRP in endothelial cells may be one of the explanations 
for its abundant expression in lung, which is a highly 
vascularized tissue. Further investigation is required to 
know if DRP is expressed in cells other than the endo- 
thelial cells in lung. 
In conclusion, we reported the purification of DRP 
from lung and skeletal muscle. The present work would 
allow for the direct biochemical study of DRP which is 
necessary to confirm structural and functional predic- 
tions deduced from the cDNA sequence [12,24], and 
allow us to address the possibility of post-translational 
modifications important o the physiological function 
of DRP in non-muscle tissues and cells. We also demon- 
strated the expression of DRP in pulmonary artery en- 
dothelial cells. Interestingly, both endothelial and mus- 
cle cells are highly distensible when exposed to mechan- 
ical stress. As a membrane cytoskeletal protein, DRP 
could be playing an important role in the mechanical 
stress mechanisms of endothelial cells [35], in analogy 
to dystrophin of muscle cells [8,10]. The upregulation of 
DRP in dystrophin-deficient muscle was recently pro- 
posed as one of the potential therapies for DMD [18- 
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Fig. 5. Immunoprecipitation of DRP from cultured pulmonary artery 
endothelial cells. The voids of digitonin-extracts after incubation with 
the anti-DRP immunoaffinity beads (lane 2) or control beads (lane 1) 
are shown. Shown are the gel stained with Coomassie blue (CB) and 
the nitrocellulose transfers immunostained with antibody against 
DRP (C'-DRP). 
20,22,23]. Ident i f icat ion o f  DRP in endothel ia l  cells 
raises a serious quest ion  concern ing  this possibi l i ty. For  
such a therapy to be successful, the upregu la t ion  o f  
DRP should  be specific to muscle cells and should  not  
involve endothel ia l  cells, since the overexpress ion o f  
DRP in endothel ia l  cells cou ld  affect b lood  c irculat ion.  
I f  d i f ferent p romoters  for muscle and endothel ia l  cell 
DRP  are identif ied, a muscle-speci f ic  p romoter  cou ld  be 
uti l ized for the upregu la t ion  o f  DRP in muscle  cells. 
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